Prebiotics and Probiotics in Infant Formulae - Prebiotics and Probiotics Ingredients - page 335

201. Folster-Holst, R. et al. Prospective, randomized controlled trial on Lactobacillus rham-
nosus in infants with moderate to severe atopic dermatitis. Br J Dermatol ., 155, 1256,
2006.
202. Kalliomaki, M. et al. Distinct patterns of neonatal gut microflora in infants in whom
atopy was and was not developing. J Allergy Clin Immunol ., 107, 129, 2001.
203. Rautava, S., Kalliomaki, M., and Isolauri, E. Probiotics during pregnancy and breast
feeding might confer immunomodulatory protection against atopic disease in the infant.
J Allergy Clin Immunol ., 109, 119, 2002.
204. Kalliomaki, M. et al. Probiotics and prevention of atopic disease: 4-year follow-up of a
randomised placebo-controlled trial. Lancet, 361, 1869, 2003.
205. Kirjavainen, P.V., Salminen, S.J., and Isolauri, E. Probiotic bacteria in the management
of atopic disease: Underscoring the importance of viability. J Pediatr Gastroenterol
Nutr ., 36, 223, 2003.
206. Kalliomaki, M. et al. Probiotics during the first 7 years of life: A cumulative risk reduc-
tion of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. , 119,
1019, 2007.
207. Rosenfeldt, V. et al. Effect of probiotic Lactobacillus strains in children with atopic
dermatitis. J Allergy Clin Immunol ., 111, 389, 2003.
208. Rosenfeldt, V. et al. Effect of probiotics on gastrointestinal symptoms and small intesti-
nal permeability in children with atopic dermatitis. J Pediatr ., 145, 612, 2004.
209. Abrahamsson, T.R. et al. Probiotics in prevention of IgE-associated eczema: A double-
blind, randomized, placebo-controlled trial. J Allergy Clin Immunol ., 119, 1174, 2007.
210. Weston, S. et al. Effects of probiotics on atopic dermatitis: A randomised controlled
trial. Arch Dis Child , 90, 892, 2005.
211. Collado, M.C. et al. Adhesion of selected Bifidobacterium strains to human intestinal
mucus and the role of adhesion in enteropathogen exclusion. J Food Prot ., 68, 2672,
2005.
212. Collado, M.C. et al. Production of bacteriocin-like inhibitory compounds by human
fecal Bifidobacterium strains. J Food Prot., 68, 1034, 2005.
213. Matsumoto, T. et al. Oral administration of Bifidobacterium longum prevents gut-derived
Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol ., 104, 672, 2007.
214. van Minnen, L.P. et al. Modification of intestinal flora with multispecies probiotics
reduces bacterial translocation and improves clinical course in a rat model of acute pan-
creatitis. Surgery , 141, 470, 2007.
215. Rayes, N. et al. Influence of probiotics and fibre on the incidence of bacterial infections
following major abdominal surgery—Results of a prospective trial. Z Gastroenterol ., 40,
869, 2002.
216. Rayes, N. et al. Supply of pre- and probiotics reduces bacterial infection rates after liver
transplantation—A randomized, double-blind trial. Am J Transplant ., 5, 125, 2005.
217. Kotzampassi, K. et al. Benefits of a synbiotic formula (Synbiotic 2000Forte(R)) in criti-
cally ill trauma patients: Early results of a randomized controlled trial. World J Surg .,
30, 1848, 2006.
218. Besselink, M.G.H. et al., Probiotic prophylaxis in predicted severe pancreatitis: A ran-
domized, double-blind, placebo-controlled trial. Lancet , 371, 651, 2008.
219. Hatakka, K. et al. Effect of long term consumption of probiotic milk on infections in chil-
dren attending day care centres: Double blind, randomised trial. Br Med J. , 322, 1327,
2001.